Company

History

HISTORY

2018

  • 2018 11
    Obtained MFDS (Ministry of Food and Drug Safety) approval for SmartBiopsy™ Time Lapse Incubator (CTI020). Listed on KOSDAQ.
  • 2018 09
    Obtained CE certification for SmartBiopsy™ IF Stainer (CST030). Signed a contract for a preclinical anti-cancer drug project (Client W).
  • 2018 08
    Obtained CE certification for SmartBiopsy™ Cell Isolator (CIS030) and Cell Image Analyzer (CIA041). Signed a contract for a domestic CTC analysis project (Samsung Medical Center). Signed a contract for a CTC analysis project (Client C).
  • 2018 06
    Signed a contract for a CTC analysis project (Yonsei University Severance Hospital).
  • 2018 05
    Relocated headquarters (Beopwon-ro, Songpa-gu, Seoul).
  • 2018 03
    Signed a contract for a CTC analysis project (Seoul St. Mary's Hospital).
  • 2018 02
    Signed the 4th contract with Daiichi Sankyo.
  • 2018 01
    Obtained MFDS (Ministry of Food and Drug Safety) approval for SmartBiopsy™ Cell Image Analyzer (CIA040).

2017

  • 2017 09
    Obtained MFDS (Ministry of Food and Drug Safety) approval for SmartBiopsy™ Cell Image Analyzer (CIA030) and Cell Isolator (CIS030). Signed a biomarker discovery contract (National Cancer Center (NCC) and ABL Bio).
  • 2017 07
    Selected for the Future Growth Engine Flagship Project (Awarded the Minister’s Prize by the Ministry of Science and ICT).
  • 2017 06
    Signed the 3rd contract with Daiichi Sankyo. Signed a contract for a CTC analysis project (Seoul St. Mary's Hospital).
  • 2017 03
    Obtained GMP certification for in vitro diagnostic (IVD) reagents. Obtained FDA approval for the Isolation Kit. Signed a contract for an anti-cancer drug efficacy validation project (ABL Bio). Signed a contract for a treatment efficacy evaluation project (Seoul St. Mary's Hospital).

2016

  • 2016 12
    Acquired INNOBIZ (Innovative Business) certification. Signed the 2nd contract with Daiichi Sankyo.
  • 2016 11
    Selected as a Leading Company in Industrial Convergence.
  • 2016 10
    Selected for the Post-Genome Multi-Ministerial Genome Project by the Ministry of Trade, Industry and Energy (MOTIE).
  • 2016 07
    Obtained FDA approval and filed PMDA notification (Japan) for IF Stainer and Time Lapse Incubator. Filed PMDA notification (Japan) for Cell Image Analyzer. Signed the 1st contract with Daiichi Sankyo.
  • 2016 06
    Completed domestic product notification for IF Stainer, Cell Image Analyzer, and Time-Lapse Incubator.
  • 2016 05
    Obtained regulatory approval for Cell Isolator in China.
  • 2016 04
    Filed PMDA (Japan) notification and completed domestic product notification for Cell Isolator. Obtained Medical Device Manufacturing License from PMDA.
  • 2016 03
    Obtained GMP certification for in vitro diagnostic (IVD) medical devices. Obtained CE marking for Cell Isolator. Obtained ISO 13485 certification and FDA approval for Cell Isolator.

2014

  • 2014 02
    Obtained MFDS (Ministry of Food and Drug Safety) medical device manufacturing license and product approval for the cell isolation chip.

2013

  • 2013 10
    Selected for the New Growth Engine Equipment Competitiveness Enhancement Project by Ministry of Trade, Industry and Energy (MOTIE).
  • 2013 06
    Selected for the Advanced Technology Center (ATC) project by Ministry of Trade, Industry and Energy (MOTIE). Selected for the Technology Innovation Development Project by the Small and Medium Business Administration (SMBA).
  • 2013 02
    Relocated headquarters (Chungmin-ro, Songpa-gu, Seoul).